Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;330:1024 (30 April), doi:10.1136/bmj.330.7498.1024
| The first 150 words of the full text of this article appear below. |
EDITORBased on a complicated statistical model, Olsen et al reported that the breast cancer mortality in Copenhagen dropped by 25% for women aged 50-79 when comparing mortality in the screening period (1991-2001) with a pre-screening period (1981-91) and claimed that this decrease was caused by screening.1
According to Statistics Denmark, 217 breast cancer deaths occurred in Copenhagen in the age group 35-54 years in the period 1981-90 and 196 deaths in 1991-2000.2 By comparing these data with those in the article by Olsen et al we calculate that less than 5% of the breast cancer mortality in this age group is caused by tumours diagnosed after age 50 years when women were invited to screening. The number of exposure years increased from about 484 000 to about 538 000. This gives a significant 19% (age adjusted) reduction in breast cancer mortality in the age group 35-54 years. No
Per-Henrik Zahl, senior statistician
Norwegian Institute of Public Health, PO Box 4404, N-0403 Oslo, Norway
Jan Mæhlen, professor
Department of Pathology, Ullevål University Hospital, N-0407 Oslo, Norway jan.mahlen@medisin.uio.no
Read all Rapid Responses